key: cord-1006216-47c3ayj1 authors: Racovita, Monica; Wheeler, Eleanor; Wait, Suzanne; Bancroft, Dani; Eastabrook, Rowan; Albreht, Tit; Baird, Anne-Marie; Jassem, Jacek; McNamara, Aoife; Novello, Silvia; Radu-Loghin, Cornel; van Meerbeeck, Jan P. title: Lung cancer in Europe: The way forward date: 2022-02-15 journal: Tob Prev Cessat DOI: 10.18332/tpc/146645 sha: 4d7b61dc59d489b7ba8d8acf9dbaee26073bb319 doc_id: 1006216 cord_uid: 47c3ayj1 nan Lung cancer causes more deaths than any other cancer, but for too long, it has not been given the policy attention it deserves. Lung cancer is the main cause of cancer-related deaths in Europe 1 , and its burden will remain high for several decades to come. Even though smoking rates are gradually declining 2 , people who used to smoke remain at high risk of lung cancer for many years after quitting 3 , and environmental factors such as air pollution are a growing cause of lung cancer in the entire population 4 . We have the means to reduce the burden of lung cancer on our society, but it will require a comprehensive and integrated approach. Importantly, we need to dispel the perception that lung cancer is a self-inflicted condition. We could start by treating smoking as an addiction and reducing stigma towards both smoking and lung cancer. Early detection needs to be enhanced by implementing largescale screening programmes that target high-risk individuals, alongside smoking cessation programmes. The evidence is clear that screening high-risk individuals using low-dose computed tomography scans offers a safe and effective way to shift diagnosis to earlier stages and reduce mortality from lung cancer 5, 6 . Complementary approaches, such as incidental pulmonary nodule identification, management protocols and rapid referral pathways from primary to secondary care, are also important to improve early detection 7, 8 . Improvements to lung cancer care pathways are needed to ensure all people have access to multidisciplinary care that encompasses specialist diagnosis, personalised treatments, and palliative and survivorship care 7, 8 . Finally, targeted efforts are required to reduce geographical and socioeconomic disparities in access and outcomes 9, 10 . Making these changes can deliver benefits beyond lung cancer. Targeted screening programmes offer the opportunity for early detection of other non-communicable diseases (NCDs), such as chronic obstructive pulmonary disease and some forms of heart disease [11] [12] [13] . Tackling lung cancer can help countries progress towards reducing the overall burden of NCDs on their societies and contribute to greater health system sustainability. With the implementation of Europe's Beating Cancer Plan and as we look to post-COVID recovery, we have the opportunity to put in place what is needed to improve outcomes for people with lung cancer and reduce the burden the condition poses on our societies. Lung cancer has, for too long, been denied due attention as a public health priority. The time to act is now. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer Global trends of lung cancer mortality and smoking Tob Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung Cancer Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial Reduced lung-cancer mortality with low-dose computed tomographic screening Contemporary issues in the implementation of lung cancer screening Initiatives to Accelerate the Diagnostic Phase of Cancer Care: An Environmental Scan. Institute of Health Economics PHE screening inequalities strategy Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program Evaluation of cardiovascular risk in a lung cancer screening cohort Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort